Last reviewed · How we verify
A Pilot Study for Ginkgolides Meglumine Injection Skin Testing
This pilot study is designed to explore the optimal concentration and method of Ginkgolides Meglumine Injection skin testing and to evaluate the value of skin test in predicting any possible allergic reactions to Ginkgolides Meglumine Injection.
Details
| Lead sponsor | Jiangsu Kanion Pharmaceutical Co., Ltd |
|---|---|
| Phase | Phase 4 |
| Status | COMPLETED |
| Enrolment | 149 |
| Start date | 2014-06 |
Conditions
- Allergy
Interventions
- 0.1mg/ml Ginkgolides Meglumine Injection
- 1mg/ml Ginkgolides Meglumine Injection
- 5mg/ml Ginkgolides Meglumine Injection
Primary outcomes
- The rate of allergic reaction and analyze all kinds of positive reactions after skin prick test with different doses of Ginkgolides Meglumine Injection. — 15-20 minutes after skin prick tests.
- The rate of allergic reaction and analyze all kinds of positive reactions after using intradermal tests of different doses of Ginkgolides Meglumine Injection. — 15-20 minutes after intradermal tests.
Countries
China